Ertumaxomab Antibody
Ertumaxomab is a bispecific antibody targeting HER2/neu and CD3, which engages Fcγ receptors to form a tri-cell complex for T-cell-mediated tumor cell killing. It has been investigated in clinical research for HER2-positive breast cancer, with studies encompassing both in vitro and in vivo experimental models.
Product Specifications
Target
Integrin
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Signal Transduction
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
